Organoids and Spheroids Market Size, Share & Industry | 2031

Organoids and Spheroids Market Size, Share & Industry | 2031

Segments - Organoids and Spheroids Market by Method (Spinning Bioreactor, Extracellular Matrix Scaffold, Hanging Drop, Magnetic Levitation, Low Adherent Culture Plate, and Others), Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing), End-user (Biotechnology & Pharmaceutical Industries, Academic & Research Institutes, and Hospitals & Diagnostic Centers), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-184 | 4.1 Rating | 70 Reviews | 156 Pages | Format : PDF Excel PPT

Report Description


The global organoids and spheroids market size was USD 405.8 Mn in 2022 and is likely to reach USD 2100 Mn by 2031, expanding at a CAGR of 22.6% during 2023–2031. The market growth is attributed to the increase in the demand for cell therapy and tissue engineering.

Organoids and spheroids are 3D cell culture units that are cultured with various techniques. These 3D cell culture units are majorly used as building blocks in the generation of complex organs and tissues. 3D spheroids are considered to be essential aspects in the field of regenerative medicine science and tissue engineering. Organoids are used for therapeutic purposes such as insulin production, misfiring stem cells, and examining brain neurons.

Global Organoids and Spheroids Market Outlook

With the help of organoids, researchers study several processes that happen in the body. Organoids and spheroids have a similar structure to original organs and carry human genetic information. Organoids are replicas of human organs such as lungs, intestines, kidney, brain, stomachs, and livers. This type of organoid model shows phenotypic traits of the organ they are grown from and exhibits self-regulation potential.

Organoids are derived from embryonic or adult stem cells. These cells divide and produce various types of cells. Organoids are complex clusters while spheroids are well-designed cell aggregates used as engineered cancer models. Moreover, spheroids are derived from mammary glands, tumor tissue, hepatocytes, and embryoid bodies.

Spheroids have importance in cancer treatment as it mimics the main therapeutics resistance patterns of solid tumors. It recapitulates the basic 3D structure of tumors, such as central necrosis, multicellular structure, and proliferation gradients depending on tumor type. This 3D cell culture is produced in vitro cultures in optimum lab scenarios and used in various applications to study the biological process on a cellular level.

The COVID-19 pandemic has moderately affected biotechnology and pharmaceutical companies. Moreover, increased R&D for developing regenerative medicines for treating COVID-19 patients and rapid development in stem cell therapy research propel the market growth. For instance, scientists have developed miniature lungs to study the mechanism of the entry of SARS-CoV-2. Organoids aid in the study of the defense mechanism of tissue against SARC-CoV-2. This has a great impact on vaccine development.

Organoids and Spheroids Market Dynamics

Major Drivers

Rising demand for organoid cultures in the drug development process is anticipated to fuel the market growth during the forecast period. Organoid technology has applications in genetic mutation, gene assessment, and tumor modelling. Moreover, organoid 3D cell cultures are used in cancer research as cancer prevalence is rising. Cancer research is rising due to the rising investments in R&D activities.

Exiting Restraints

Complexity in the reconstruction of complex in vivo cellular diversity and signaling of organs or tumors is expected to hamper the market. In addition, high cost of implementation is anticipated to hinder the market during the forecast period.

Emerging Opportunities

Rapid technological developments in 3D spheroid technology are expected to fuel market growth. For instance, AMS Biotechnology (AMSBIO) introduced Cultrex Organoid Progenitor Cells, which can be optimized by the use of different sets of extracellular matrices. Researchers are able to direct cell activity by controlling the culture microenvironment. Cultrex spheroid proliferation/viability and invasion assays provided by the company stimulate the development of cohesive spheroids even in low adhesion environments.

Organoids-on-a-chip technology and the development of high throughput Organoids-on-a-chip technology propel the use of patient-derived organoids in clinical practice and facilitate therapeutic decision-making. Organoids-on-a-chip technology is microfabricated cell culture devices. Organ chips have microfluidic channels lined by living human organ-specific cells. The construction of any organ-on-a-chip system is guided by design principles based on a reductionist analysis of its target organ.

Global Organoids and Spheroids Market Dynamics

Scope of the Organoids and Spheroids Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
 

Attributes

Details

Report Title

Organoids and Spheroids Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Method (Spinning Bioreactor, Extracellular Matrix Scaffold, Hanging Drop, Magnetic Levitation, Low Adherent Culture Plate, and Others), Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing), and End-user (Biotechnology & Pharmaceutical Industries, Academic & Research Institutes, and Hospitals & Diagnostic Centers)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

3D Biotek LLC; 3D Biomatrix; AMS Biotechnology Limited; ATCC, Cellesce Ltd.; Corning Incorporated; Greiner Bio-One; HubrechtOrganoid Technology; InSphero/Perkin Elmer; Kuraray; Lonza; Merck KGaA; Prellis Biologics; STEMCELL Technologies Inc.; and Thermo Fisher Scientific, Inc.

Organoids and Spheroids Market Segment Insights

On the basis of method, the organoids and spheroids market is segmented into spinning bioreactor, extracellular matrix scaffold, hanging drop, magnetic levitation, low adherent culture plate, and others. The extracellular matrix scaffold segment is anticipated to register a robust growth rate in the coming years as it is widely used for the large production of organoids and spheroids. The cost-effectiveness of this method and the ability to produce organoids and spheroids in less time are likely to accelerate segment growth.

Global Organoids and Spheroids Market Method

Based on application, the market is divided into developmental biology, personalized medicine, regenerative medicine, disease pathology studies, and drug toxicity & efficacy testing. The biology development segment constituted a significant share of the market. Organoid and spheroid culture systems are used for biological development.

The regenerative medicine segment is projected to constitute a large market share during the forecast period, as organoid and spheroid transplantation from adult stem cells helps to replace diseased tissue or organ.

On the basis of end-user, the market is segregated into biotechnology & pharmaceutical industries, academic & research institutes, and hospitals & diagnostic centers. The biotechnology and pharmaceutical industries segment is projected to expand at a significant pace during the forecast period. Potential organoid and spheroid clinical applications have encouraged pharmaceutical start-ups to enter this market. Furthermore, the high consumption of organoids and spheroids in pre-clinical drug discovery by pharmacists is expected to boost segment growth.

Global Organoids and Spheroids Market End User

In terms of region, the global market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, due to an increase in organoid-based models of biotechnology and spheroid research in the US and Canada. Moreover, the presence of key players including Thermo Fisher Scientific, Corning, and PerkinElmer is anticipated to propel market growth considerably.

Global Organoids and Spheroids Market Regions


Advanced technology is employed to overcome limitations faced by the 2D cell culture platforms. 3D spheroids provide a suitable environment that mimics the properties of human tissue structures. Three-dimensional cell cultures serve better models and represent in vivo physiological conditions closely. 3D cell cultures are prevalent and enable cell-to-cell communication.

A study conducted by the American Association for the Study of Liver Diseases (AASLD) on the advent of organoid medicine in hepatology was supported by AASLD Foundation (Pinnacle Research Award); North American Society of Gastroenterology Hepatology and Nutrition (NASPGHAN) Foundation (George Ferry Young Investigator Award); and Cincinnati Children’s Research Foundation (Procter Scholar Award).

For instance, a February 2020 study conducted by the American Association for the Study of Liver Diseases (AASLD) regarding the advent of organoid medicine in hepatology was supported by AASLD Foundation (Pinnacle Research Award); North American Society of Gastroenterology Hepatology and Nutrition (NASPGHAN) Foundation (George Ferry Young Investigator Award); and Cincinnati Children’s Research Foundation (Procter Scholar Award).

The market in Asia Pacific is anticipated to expand at a substantial pace during the forecast period, due to the rise in partnerships among key market players and constant developments in the field of stem cell research. The market growth is enhancing, due to the increasing partnerships in the market. For instance, Nichirei Biosciences and UPM Biomedicals partnered together to offer UPM culture products in Japan in March 2020. This development enhanced the availability of natural hydrogels for organoid and spheroid culture

Segments

The global organoids and spheroids market has been segmented on the basis of

Method

  • Spinning Bioreactor
  • Extracellular Matrix Scaffold
  • Hanging Drop
  • Magnetic Levitation
  • Low Adherent Culture Plate
  • Others

Application

  • Developmental Biology
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Pathology Studies
  • Drug Toxicity & Efficacy Testing

End-user

  • Biotechnology & Pharmaceutical Industries
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • 3D Biotek LLC
  • 3D Biomatrix
  • AMS Biotechnology Limited
  • ATCC, Cellesce Ltd.
  • Corning Incorporated
  • Greiner Bio-One
  • HubrechtOrganoid Technology
  • InSphero/Perkin Elmer
  • Kuraray
  • Lonza
  • Merck KGaA
  • Prellis Biologics
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific, Inc.

Competitive Landscape

Key players competing in the global organoids and spheroids market are 3D Biotek LLC; 3D Biomatrix; AMS Biotechnology Limited; ATCC, Cellesce Ltd.; Corning Incorporated; Greiner Bio-One; HubrechtOrganoid Technology; InSphero/Perkin Elmer; Kuraray; Lonza; Merck KGaA; Prellis Biologics; STEMCELL Technologies Inc.; and Thermo Fisher Scientific, Inc.

Key players are actively engaged in R&D programs and aim at the expansion of manufacturing units to expand their consumer base and increase their product portfolio. For instance, Perkin Elmer is a leading company based in the United States, that offers a wide portfolio of platforms for handling, detection, and analysis of spheroids.

Global Organoids and Spheroids Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Organoids and Spheroids Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Organoids and Spheroids Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Organoids and Spheroids Market - Supply Chain
  4.5. Global Organoids and Spheroids Market Forecast
     4.5.1. Organoids and Spheroids Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Organoids and Spheroids Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Organoids and Spheroids Market Absolute $ Opportunity
5. Global Organoids and Spheroids Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Organoids and Spheroids Market Size and Volume Forecast by Applications
     5.3.1. Developmental Biology
     5.3.2. Personalized Medicine
     5.3.3. Regenerative Medicine
     5.3.4. Disease Pathology Studies
     5.3.5. Drug Toxicity & Efficacy Testing
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Organoids and Spheroids Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Organoids and Spheroids Market Size and Volume Forecast by End Users
     6.3.1. Biotechnology & Pharmaceutical Industries
     6.3.2. Academic & Research Institutes
     6.3.3. Hospitals & Diagnostic Centers
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Organoids and Spheroids Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Organoids and Spheroids Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Organoids and Spheroids Demand Share Forecast, 2019-2026
8. North America Organoids and Spheroids Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Organoids and Spheroids Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Organoids and Spheroids Market Size and Volume Forecast by Applications
     8.4.1. Developmental Biology
     8.4.2. Personalized Medicine
     8.4.3. Regenerative Medicine
     8.4.4. Disease Pathology Studies
     8.4.5. Drug Toxicity & Efficacy Testing
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Organoids and Spheroids Market Size and Volume Forecast by End Users
     8.7.1. Biotechnology & Pharmaceutical Industries
     8.7.2. Academic & Research Institutes
     8.7.3. Hospitals & Diagnostic Centers
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Organoids and Spheroids Demand Share Forecast, 2019-2026
9. Latin America Organoids and Spheroids Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Organoids and Spheroids Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Organoids and Spheroids Market Size and Volume Forecast by Applications
     9.4.1. Developmental Biology
     9.4.2. Personalized Medicine
     9.4.3. Regenerative Medicine
     9.4.4. Disease Pathology Studies
     9.4.5. Drug Toxicity & Efficacy Testing
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Organoids and Spheroids Market Size and Volume Forecast by End Users
     9.7.1. Biotechnology & Pharmaceutical Industries
     9.7.2. Academic & Research Institutes
     9.7.3. Hospitals & Diagnostic Centers
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Organoids and Spheroids Demand Share Forecast, 2019-2026
10. Europe Organoids and Spheroids Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Organoids and Spheroids Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Organoids and Spheroids Market Size and Volume Forecast by Applications
     10.4.1. Developmental Biology
     10.4.2. Personalized Medicine
     10.4.3. Regenerative Medicine
     10.4.4. Disease Pathology Studies
     10.4.5. Drug Toxicity & Efficacy Testing
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Organoids and Spheroids Market Size and Volume Forecast by End Users
     10.7.1. Biotechnology & Pharmaceutical Industries
     10.7.2. Academic & Research Institutes
     10.7.3. Hospitals & Diagnostic Centers
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Organoids and Spheroids Demand Share Forecast, 2019-2026
11. Asia Pacific Organoids and Spheroids Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Organoids and Spheroids Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Organoids and Spheroids Market Size and Volume Forecast by Applications
     11.4.1. Developmental Biology
     11.4.2. Personalized Medicine
     11.4.3. Regenerative Medicine
     11.4.4. Disease Pathology Studies
     11.4.5. Drug Toxicity & Efficacy Testing
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Organoids and Spheroids Market Size and Volume Forecast by End Users
     11.7.1. Biotechnology & Pharmaceutical Industries
     11.7.2. Academic & Research Institutes
     11.7.3. Hospitals & Diagnostic Centers
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Organoids and Spheroids Demand Share Forecast, 2019-2026
12. Middle East & Africa Organoids and Spheroids Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Organoids and Spheroids Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Organoids and Spheroids Market Size and Volume Forecast by Applications
     12.4.1. Developmental Biology
     12.4.2. Personalized Medicine
     12.4.3. Regenerative Medicine
     12.4.4. Disease Pathology Studies
     12.4.5. Drug Toxicity & Efficacy Testing
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Organoids and Spheroids Market Size and Volume Forecast by End Users
     12.7.1. Biotechnology & Pharmaceutical Industries
     12.7.2. Academic & Research Institutes
     12.7.3. Hospitals & Diagnostic Centers
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Organoids and Spheroids Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Organoids and Spheroids Market: Market Share Analysis
  13.2. Organoids and Spheroids Distributors and Customers
  13.3. Organoids and Spheroids Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. 3D Biotek LLC
     13.4.2. 3D Biomatrix
     13.4.3. AMS Biotechnology Limited
     13.4.4. ATCC, Cellesce Ltd.
     13.4.5. Corning Incorporated
     13.4.6. Greiner Bio-One
     13.4.7. HubrechtOrganoid Technology
     13.4.8. InSphero/Perkin Elmer
     13.4.9. Kuraray
     13.4.10. Lonza
     13.4.11. Merck KGaA
     13.4.12. Prellis Biologics
     13.4.13. STEMCELL Technologies Inc.
     13.4.14. Thermo Fisher Scientific, Inc.

Methodology

Our Clients

Honda Motor Co. Ltd.
Siemens Healthcare
General Electric
Deloitte
General Mills
Pfizer
Dassault Aviation
Nestle SA